These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 15337607)

  • 21. Reconstitution of the fatty acid hydroxylase activity of cytochrome P450BM-3 utilizing its functional domains.
    Sevrioukova I; Truan G; Peterson JA
    Arch Biochem Biophys; 1997 Apr; 340(2):231-8. PubMed ID: 9143326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the interactions of cytochrome b5 with flavocytochrome P450 BM3 and its domains.
    Noble MA; Girvan HM; Smith SJ; Smith WE; Murataliev M; Guzov VM; Feyereisen R; Munro AW
    Drug Metab Rev; 2007; 39(2-3):599-617. PubMed ID: 17786641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affinity isolation and characterization of cytochrome P450 102 (BM-3) from barbiturate-induced Bacillus megaterium.
    Black SD; Linger MH; Freck LC; Kazemi S; Galbraith JA
    Arch Biochem Biophys; 1994 Apr; 310(1):126-33. PubMed ID: 8161195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
    Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
    Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of key active-site residues in flavocytochrome P450 BM3.
    Noble MA; Miles CS; Chapman SK; Lysek DA; MacKay AC; Reid GA; Hanzlik RP; Munro AW
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):371-9. PubMed ID: 10191269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparative use of isolated CYP102 monooxygenases -- a critical appraisal.
    Eiben S; Kaysser L; Maurer S; Kühnel K; Urlacher VB; Schmid RD
    J Biotechnol; 2006 Aug; 124(4):662-9. PubMed ID: 16716428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The unusual redox properties of flavocytochrome P450 BM3 flavodoxin domain.
    Hanley SC; Ost TW; Daff S
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1418-23. PubMed ID: 15555585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving catalytic properties of P450 BM3 haem domain electrodes by molecular Lego.
    Fantuzzi A; Meharenna YT; Briscoe PB; Sassone C; Borgia B; Gilardi G
    Chem Commun (Camb); 2006 Mar; (12):1289-91. PubMed ID: 16538250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
    Urlacher VB; Schmid RD
    Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074
    [No Abstract]   [Full Text] [Related]  

  • 30. [Electrochemical measurement of intraprorein and interprotein electron transfer].
    Shumiantseva VV; Bulko TV; Lisitsina VB; Urlakher VB; Kuzikov AB; Suprun EV; Archakov AI
    Biofizika; 2013; 58(3):453-60. PubMed ID: 24159813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P450BM-3: absolute configuration of the primary metabolites of palmitic acid.
    Truan G; Komandla MR; Falck JR; Peterson JA
    Arch Biochem Biophys; 1999 Jun; 366(2):192-8. PubMed ID: 10356283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flavin supported fatty acid oxidation by the heme domain of Bacillus megaterium cytochrome P450BM-3.
    Gonvindaraj S; Li H; Poulos TL
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1745-9. PubMed ID: 7945324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of nitric oxide with cytochrome P450 BM3.
    Quaroni LG; Seward HE; McLean KJ; Girvan HM; Ost TW; Noble MA; Kelly SM; Price NC; Cheesman MR; Smith WE; Munro AW
    Biochemistry; 2004 Dec; 43(51):16416-31. PubMed ID: 15610036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation of flavin semiquinone during the reduction of P450 BM3 reductase domain with NADPH.
    Munro AW; Coggins JR; Lindsay JG; Daff S; Chapman SK
    Biochem Soc Trans; 1996 Feb; 24(1):18S. PubMed ID: 8674656
    [No Abstract]   [Full Text] [Related]  

  • 35. Catalytically self-sufficient P450 CYP102 (cytochrome P450 BM-3): resonance Raman spectral characterization of the heme domain and of the holoenzyme.
    Hudeèek J; Baumruk V; Anzenbacher P; Munro AW
    Biochem Biophys Res Commun; 1998 Feb; 243(3):811-5. PubMed ID: 9500975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dicamba monooxygenase: structural insights into a dynamic Rieske oxygenase that catalyzes an exocyclic monooxygenation.
    D'Ordine RL; Rydel TJ; Storek MJ; Sturman EJ; Moshiri F; Bartlett RK; Brown GR; Eilers RJ; Dart C; Qi Y; Flasinski S; Franklin SJ
    J Mol Biol; 2009 Sep; 392(2):481-97. PubMed ID: 19616009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probing electron transfer in flavocytochrome P-450 BM3 and its component domains.
    Munro AW; Daff S; Coggins JR; Lindsay JG; Chapman SK
    Eur J Biochem; 1996 Jul; 239(2):403-9. PubMed ID: 8706747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450.
    Otey CR; Bandara G; Lalonde J; Takahashi K; Arnold FH
    Biotechnol Bioeng; 2006 Feb; 93(3):494-9. PubMed ID: 16224788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deflavination of cytochrome P450 BM3 by treatment with guanidinium chloride.
    Munro AW; Coggins JR; Lindsay JG; Kelly S; Price NC
    Biochem Soc Trans; 1996 Feb; 24(1):19S. PubMed ID: 8674659
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of the conserved threonine in P450 BM3 oxygen activation: substrate-determined hydroxylation activity of the Thr268Ala mutant.
    Cryle MJ; De Voss JJ
    Chembiochem; 2008 Jan; 9(2):261-6. PubMed ID: 18161730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.